文献速递男科与性医学

输精管结扎术前常规精液冷冻保存与手术取精或输精管复通相比不具有成本效益且不提高活产率

Routine Sperm Cryopreservation Before Vasectomy Is not Cost-effective and Does not Increase Live Birth Rates Compared to Surgical Sperm Retrieval or Vasectomy Reversal.
PubMed 文献 · Urology · 2025-01-10

该研究通过范围综述收集精液冷冻保存、输精管复通、手术取精及辅助生殖技术(ART)的疗效与结局数据,并从美国机构获取成本数据,构建TreeAge Pro成本效果模型模拟三种情景。主要结局为每活产成本,次要结局为总活产率。结果显示,输精管结扎术前精液冷冻保存每活产成本(140,247美元,范围48,232-552,807美元)显著高于生育力恢复(20,458美元,范围20,458-30,698美元);且根据已发表文献值,生育力恢复组的妊娠成功率(62%,范围44%-66%)似乎略高于冷冻保存组(46%,范围36%-58%)。

要点

  • 输精管结扎术前常规精液冷冻保存每活产成本(140,247美元)显著高于生育力恢复(20,458美元)。
  • 根据已发表文献值,生育力恢复组妊娠成功率(62%)似乎略高于冷冻保存组(46%)。
  • 无生育风险因素的患者应被告知术前冷冻保存的额外费用及需行ART,但仍可允许其按意愿进行。

核心结论

  • 输精管结扎术前常规精液冷冻保存给患者和医疗系统带来显著更高的成本,且与通过手术取精或输精管复通的生育力恢复相比似乎不提高活产率。
  • 无生育风险因素的患者应被告知术前冷冻保存的额外费用及需行ART,但仍应允许其按意愿进行。

研究设计与样本

  • 范围综述收集精液冷冻保存、输精管复通、手术取精及ART的疗效与结局数据。
  • 成本数据来自美国开展冷冻保存和男科临床诊疗的机构。
  • 使用TreeAge Pro成本效果建模软件构建成本效果模型,包含三种情景:采用中位数预期参数值的平衡情景、有利于术前冷冻保存的假设/变量情景、有利于生育力恢复的情景。
  • 主要结局为每活产成本,次要结局为总活产率。

主要发现

  • 术前冷冻保存每活产成本为140,247美元(范围48,232-552,807美元),显著高于生育力恢复的20,458美元(范围20,458-30,698美元)。
  • 根据已发表文献值,生育力恢复组妊娠成功率为62%(范围44%-66%),冷冻保存组为46%(范围36%-58%),生育力恢复组似乎略高。

临床怎么用

  • 无生育风险因素的患者应被告知输精管结扎术前精液冷冻保存的额外费用及需行ART,但仍应允许其按意愿进行。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if routine pre-vasectomy sperm cryopreservation is more cost-effective than fertility restoration for patients who desire additional children following vasectomy? METHODS: A scoping review was performed to collect published data regarding efficacy and outcomes of cryopreservation, vasectomy reversal, surgical sperm retrieval, and assisted reproductive technologies (ART). Cost data were collected from US-based facilities performing cryopreservation and andrology clinical care. A cost-effectiveness model was generated using TreeAge Pro cost-effectiveness modeling software with 3 different variations representing a balanced scenario with median expected parameter values, a scenario with assumptions/variables favoring pre-vasectomy cryopreservation, and a scenario favoring fertility restoration. The primary outcome was cost per live birth and the secondary outcome was overall live birth rate. RESULTS: Pre-vasectomy cryopreservation cost ($140,247, range $48,232-$552,807 per live birth) was significantly higher than with fertility restoration ($20,458 range $20,458-$30,698). Surprisingly, pregnancy success rates appeared to be incrementally higher in the fertility restoration group (62%, range 44%-66%) compared to cryopreservation (46%, range 36%-58%) when using published literature values. CONCLUSION: Routine sperm cryopreservation prior to vasectomy conveys a significantly higher cost to patients and the healthcare system and does not appear to increase live birth rate compared to fertility restoration with sperm retrieval or vasectomy reversal. Patients without fertility risk factors should be counseled on the added cost and need for ART with pre-vasectomy cryopreservation but should still be allowed to proceed if desired.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Roth BJ, Shumaker AD, Bajic P, et al. Routine Sperm Cryopreservation Before Vasectomy Is not Cost-effective and Does not Increase Live Birth Rates Compared to Surgical Sperm Retrieval or Vasectomy Reversal. Urology. 2025. PMID: 39800322. doi:10.1016/j.urology.2024.12.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。